Experience

PharmNovo

• Sweden
• Biotechnology Research
• 1 - 100 Employee

• Chief Scientific Advisor, Founder

  • Nov 2007 - Present

  Lund, Skane County, Sweden



Pharmnovo AB

• CEO

  • Jan 2008 - Sep 2020



British Pharmacological Society

• CEO

  • 2008 - Sep 2020



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Principal Scientist

  • Jan 1998 - Jan 2008

  AstraZeneca, Mölndal Bengt von Mentzer started at AstraZeneca during the Hässle time of the company 1972 as a Research Scientist. Bengt continued to a doctoral position 1985 performed at Zoophysiology, University of Lund, Dept. of Physiology, Gothenburg and Dept. of Experimental Pharmacology and Therapeutics, University of Leicester, UK. Following more research activities Bengt worked at the University of Iowa and University of Boston with fatty acid metabolism. Bengt has published under the name Bengt Ek up until… Show more Bengt von Mentzer started at AstraZeneca during the Hässle time of the company 1972 as a Research Scientist. Bengt continued to a doctoral position 1985 performed at Zoophysiology, University of Lund, Dept. of Physiology, Gothenburg and Dept. of Experimental Pharmacology and Therapeutics, University of Leicester, UK. Following more research activities Bengt worked at the University of Iowa and University of Boston with fatty acid metabolism. Bengt has published under the name Bengt Ek up until 1995, as Bengt Ek-von Mentzer to 1998 and as Bengt von Mentzer from 2000. Bengt continued from 1998 his research at AstraZeneca with neuropeptide GPCR research. Together with George Vauqueline, Nov 2008 he published a well recognized book in Molecular Pharmacology, "G-Protein Coupled Receptors", with the under title "From Academic Concept to Pharmaceutical Research" and shortly thereafter started his own Pharmaceutical Company, Pharmnovo AB. Show less